Thursday, August 8, 2013
Publication and contact
Aurora kinase A (AURKA;
In vitro and mouse studies suggest furanopyrimidine-based
dual AURKA and AURKB inhibitors could help treat cancer. In in vitro
assays, the lead furanopyrimidine selectively inhibited AURKA and AURKB at
nanomolar IC50 values. In a mouse xenograft model for human
colorectal cancer, the lead compound decreased tumor growth compared with
vehicle without causing toxicity. Next steps could include testing the lead
compound in animal models for other cancers.
Pharmaceutical Co. Ltd.'s alisertib
a second-generation AURKA inhibitor, is in Phase III testing to treat T cell
lymphoma and Phase II testing or earlier for other cancers.
an inhibitor of AURKA and multiple tyrosine kinases, is in Phase II
testing to treat sarcoma, breast cancer and ovarian cancer and Phase I
testing for other cancers.
Pharmaceuticals Inc.'s AT9283,
a small molecule inhibitor of AURKA, AURKB, Janus
tyrosine kinase 3 (FLT3;
T315I, is in Phase II testing to treat multiple myeloma (MM)
and Phase I testing for other cancers.
Published online Aug. 8, 2013
Patent and licensing status
Shiao, H.-Y. et al. J.
Med. Chem.; published online June 28, 2013;
Contact: Hsing-Pang Hsieh, National Health Research
Institutes, Zhunan, Taiwan
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]